These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 19853028

  • 1. Development of inhalable dry powder formulation of basic fibroblast growth factor.
    Ibrahim BM, Jun SW, Lee MY, Kang SH, Yeo Y.
    Int J Pharm; 2010 Jan 29; 385(1-2):66-72. PubMed ID: 19853028
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 4. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A, Boireau H, Horta MJ, Vanbever R.
    Eur J Pharm Biopharm; 2008 Nov 21; 70(3):839-44. PubMed ID: 18620052
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C, Rouxhet PG, Ahimou F, Simon D, Culot C, Préat V, Vanbever R.
    J Control Release; 2004 Oct 19; 99(3):357-67. PubMed ID: 15451594
    [Abstract] [Full Text] [Related]

  • 7. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS, Ng ML, Kho K, Hadinoto K.
    Int J Pharm; 2011 Feb 14; 404(1-2):289-300. PubMed ID: 21093560
    [Abstract] [Full Text] [Related]

  • 8. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR, Seville PC.
    J Control Release; 2005 Dec 10; 110(1):130-40. PubMed ID: 16226334
    [Abstract] [Full Text] [Related]

  • 9. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y, Zhao M, Liu G, Tang X.
    J Pharm Pharmacol; 2007 Jul 10; 59(7):927-34. PubMed ID: 17637186
    [Abstract] [Full Text] [Related]

  • 10. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 11. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents.
    Jalalipour M, Gilani K, Tajerzadeh H, Najafabadi AR, Barghi M.
    Int J Pharm; 2008 Mar 20; 352(1-2):209-16. PubMed ID: 18164150
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G, Vanderbist F, Amighi K.
    Int J Pharm; 2009 Jan 05; 365(1-2):162-9. PubMed ID: 18782609
    [Abstract] [Full Text] [Related]

  • 13. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH, Danède F, Descamps M, Flament MP.
    Eur J Pharm Biopharm; 2008 Sep 05; 70(1):380-8. PubMed ID: 18504120
    [Abstract] [Full Text] [Related]

  • 14. Capreomycin inhalable powders prepared with an innovative spray-drying technique.
    Schoubben A, Giovagnoli S, Tiralti MC, Blasi P, Ricci M.
    Int J Pharm; 2014 Jul 20; 469(1):132-9. PubMed ID: 24747443
    [Abstract] [Full Text] [Related]

  • 15. Development of budesonide nanocluster dry powder aerosols: preformulation.
    El-Gendy N, Selvam P, Soni P, Berkland C.
    J Pharm Sci; 2012 Sep 20; 101(9):3434-44. PubMed ID: 22623018
    [Abstract] [Full Text] [Related]

  • 16. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.
    Aquino RP, Prota L, Auriemma G, Santoro A, Mencherini T, Colombo G, Russo P.
    Int J Pharm; 2012 Apr 15; 426(1-2):100-107. PubMed ID: 22301426
    [Abstract] [Full Text] [Related]

  • 17. Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders.
    Raula J, Thielmann F, Naderi M, Lehto VP, Kauppinen EI.
    Int J Pharm; 2010 Jan 29; 385(1-2):79-85. PubMed ID: 19879344
    [Abstract] [Full Text] [Related]

  • 18. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F, Aquino RP, Del Gaudio P, Colombo P, Russo P.
    Eur J Pharm Biopharm; 2009 May 29; 72(1):206-13. PubMed ID: 18996478
    [Abstract] [Full Text] [Related]

  • 19. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
    Schoubben A, Blasi P, Giontella A, Giovagnoli S, Ricci M.
    Int J Pharm; 2015 Oct 15; 494(1):40-8. PubMed ID: 26255220
    [Abstract] [Full Text] [Related]

  • 20. Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims.
    Thai A, Xiao J, Ammit AJ, Rohanizadeh R.
    Int J Pharm; 2010 Apr 15; 389(1-2):41-52. PubMed ID: 20080165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.